AI Kalpa is a healthcare startup with the vision of revolutionizing medical diagnostics through the implementation of AI and DL technologies. The company aims to address the complexities and errors associated with understanding critical information from various medical reports. Leveraging advanced DL and AI expertise, backed by clinical and biomedical knowledge, AI Kalpa is dedicated to eliminating diagnostic errors. One of their initial focuses is on Glaucoma, a condition that often leads to acute blindness and presents significant challenges in terms of understanding its progression. The company's product, Scan AI App, has been designed to quantify ONH parameters from fundus images, providing quantified Glaucoma reports. Remarkably, their AI Algorithm has demonstrated an impressive 91% accuracy in comparison to OCT and Glaucoma specialists in blind-folded studies. Founded in 2016 and based in India, AI Kalpa is positioned at the intersection of healthcare and technology, offering solutions that have the potential to significantly impact the field of diagnostics. With a strong focus on leveraging AI and DL to address critical healthcare challenges, AI Kalpa is primed to make substantial contributions to the healthcare industry. Stay tuned for updates on their innovative solutions by visiting their website or reaching out directly.
There is no investment information
No recent news or press coverage available for AI Kalpa.